Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-19T00:19:21.840Z Has data issue: false hasContentIssue false
  • English
  • Français

Dilute proparacaine for the management of acute corneal injuries in the emergency department

Published online by Cambridge University Press:  21 May 2015

Ian Michael Ball ,
Jamie Seabrook ,
Nimesh Desai ,
Larry Allen  and
Scott Anderson
Ian Michael Ball*
Affiliation:
Divisions of Emergency Medicine and Critical Care Medicine, Department of Medicine, London Health Sciences Centre, London, Ont.
Jamie Seabrook
Affiliation:
Departments of Pediatrics and Sociology, London Health Sciences Centre, London, Ont.
Nimesh Desai
Affiliation:
Department of Surgery, London Health Sciences Centre, London, Ont.
Larry Allen
Affiliation:
Department of Surgery, London Health Sciences Centre, London, Ont.
Scott Anderson
Affiliation:
Divisions of Emergency Medicine and Critical Care Medicine, Department of Medicine, London Health Sciences Centre, London, Ont.
*
Queen's University, Kingston General Hospital, 76 Stuart St., Empire 3, Kingston ON K7L 2V7, [email protected]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective:

Dogma discourages the provision of topical anesthetics to patients with corneal injuries discharged from the emergency department because of the toxicity of concentrated solutions. We compared the analgesic efficacy of dilute topical proparacaine with placebo in emergency department patients with acute corneal injuries.

Methods:

We conducted a prospective randomized controlled trial of adults with corneal injuries presenting to one of 2 tertiary care emergency departments in London, Ont. Patients were randomly assigned to groups receiving either 0.05% proparacaine or placebo drops as outpatients and were followed up to healing by a single ophthalmologist. Our primary outcome was pain reduction as measured on a 10-cm visual analog scale.

Results:

Fifteen participants from the proparacaine group and 18 participants from the placebo group completed the study. The mean age of the patients was 38.7 (standard deviation 12.3) years and the majority were male (85%). Pain reduction was significantly better in the proparacaine group than in the placebo group, with a median improvement of 3.9 (interquartile range [IQR] 1.5–5.1 ) cm on the visual analog scale versus a median improvement of 0.6 (IQR 0.2–2.0) cm (p = 0.007). The proparacaine group was more satisfied (median level of satisfaction 8.0 [IQR 6.0–9.0] cm on a 10-cm visual analog scale v. 2.6 [IQR 1.0–8.0] cm, p = 0.027). There were no ocular complications or signs of delayed wound healing in either group.

Conclusion:

Dilute topical proparacaine is an efficacious analgesic for acute corneal injuries. Although no adverse events were observed in our study population, larger studies are required to evaluate safety.

Keywords

proparacainepaincorneaabrasion
Type
Original Research • Recherche originale
Information
Canadian Journal of Emergency Medicine , Volume 12 , Issue 5 , September 2010 , pp. 389 - 394
Copyright
Copyright © Canadian Association of Emergency Physicians 2010

References

REFERENCES

1.Calder, L, Balasubramanian, S, Stiell, I. Corneal abrasion management: national survey shows lack of consensus. CJEM 2004;6:402–7.Google Scholar
2.Sher, NA, Frantz, JM, Talley, A, et al. Topical diclofenac in the treatment of ocular pain after excimer photorefractive keratectomy. Refract Corneal Surg 1993;9:425–36.CrossRefGoogle ScholarPubMed
3.Marx, JARed and painful eye. In: Rosen’s emergency medicine: concepts and clinical practice. 6th ed. Maryland Heights (MO): Mosby Elsevier; 2006. p. 291.Google Scholar
4.Mitchell, JD. Occular emergencies. In: Tintinalli, JE, Gabor, D, Stapczynski, JS, editors. Emergency medicine: a comprehensive study guide. 6th ed. New York (NY): McGraw-Hill Professional; 2004. p. 1455.Google Scholar
5.Havener, WH, Mauger, TF. Ocular pharmacology. 5th ed. St. Louis (MO): CV Mosby; 1983. p. 75–7.Google Scholar
6.Peyman, GA, Rahimy, MH, Fernandes, ML. Effects of morphine on corneal sensitivity and epithelial wound healing: implication for topical analgesia. Br J Ophthalmol 1994;78:138–41.Google Scholar
7.Duffin, RM, Olson, RJ. Tetracaine toxicity. Ann Ophthalmol 1984;16:836–8.Google Scholar
8.Epstein, DL, Paton, D. Keratitis from the misuse of corneal anesthetics. N Engl J Med 1968;279:396–9.Google Scholar
9.Bartfield, JM, Holmes, TJ, Raccio-Robak, N. A comparison of proparacaine and tetracaine eye anesthetics. Acad Emerg Med 1994;1:364–7.Google Scholar
10.Guzey, M, Ahmet, S, Dogan, B, et al. The effects of bupivicaine and lidocaine on the corneal endothelium when applied into the anterior chamber at the concentrations supplied commercially. Ophtha mo ogica 2002;216:113–7.Google Scholar
11.Eggeling, P, Pleyer, U, Hartmann, C. Corneal endothelial toxicity of different lidocaine concentrations. J Cataract Refract Surg 2000;26:1403–8.Google Scholar
12.Chang, YS, Tseng, SH, Chen, FKet al. Cytotoxicity of lidocaine or bupivacaine on corneal endothelial cells in a rabbit model. Cornea 2006;25:590–6.Google Scholar
13.Verma, S, Corbett, MC, Patmore, A, et al. A comparative study of the duration and efficacy of tetracaine 1% and bupivacaine 0.75% in controlling pain following photorefractive keratectomy (PRK). Eur J Ophthalmol 1997;7:327–33.Google Scholar
14.Brilakis, HS, Thomas, MD, Deutsch, A. Topical tetracaine with bandage soft contact lens pain control after photorefractive keratectomy. JRefract Surg. 2000;16:444–7.Google Scholar
15.Shahinian, L, Jain, S, Jager, RD, et al. Dilute topical proparacaine for pain relief after photorefractive keratectomy. Ophthalmology 1997;104:1327–31.Google Scholar
16.Price, DD, McGrath, PA, Rafii, A, et al. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983;17:45–56.Google Scholar
17.Judge, AJ, Nafaji, K, Lee, DA, et al. Corneal endothelial toxicity of topical anesthesia. Ophthalmology 1997;104:1373–9.CrossRefGoogle ScholarPubMed
18.Rocha, G, Brunette, I, Le Francois, M. Severe toxic keratopathy secondary to topical anesthetic abuse. Can J Ophthalmol 1995;30:198–202.Google Scholar
19.Pharmakakis, NM, Katsimpris, JM, Melachrinou, MP, et al. Corneal complications following abuse of topical anesthetics. Eur J Ophthalmol 2002;12:373–8.CrossRefGoogle ScholarPubMed
20.Chen, HT, Chen, KH, Hsu, WM. Toxic keratopathy associated with abuse of low dose anesthetic: a case report. Cornea 2004;23:527–9.Google Scholar
21.Ansari, H, Garibaldi, DC, Jun, AS. Anaesthetic abuse keratopathy as a manifestation of ocular Munchausen’s syndrome. Clin Experiment Ophthalmol 2006;34:81–3.Google Scholar
22.Varga, JH, Rubinfeld, RS, Wolf, TC, et al. Topical anesthetic abuse ring keratitis: report of four cases. Cornea 1997;16:424–9.Google Scholar
23.Kim, JY, Choi, YS, Lee, JH. Keratitis from corneal anesthetic abuse after photorefractive keratectomy. J Cataract Refract Surg 1997;23:447–9.Google Scholar
24.Sugar, A. Topical anesthetic abuse after radial keratectomy. J Cataract Refract Surg 1998;24:1535–7.Google Scholar